Profit Or Loss [Abstract]

Egetis Therapeutics - Filing #701621

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
38 243 SEK
40 662 SEK
Cost of sales
7 856 SEK
1 895 SEK
Other income
300,000 SEK
0 SEK
Profit (loss) from operating activities
105 681 SEK
177 299 SEK
Finance income
1 327 SEK
163,000 SEK
Finance costs
188,000 SEK
888,000 SEK
Profit (loss) before tax
104 542 SEK
178 024 SEK
Tax expense (income)
- SEK
- SEK
Profit (loss)
104 542 SEK
178 024 SEK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
6.0
26.0
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
6.0
26.0

Talk to a Data Expert

Have a question? We'll get back to you promptly.